Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,198 | 20,600 | 30,147 | 21,097 | 15,396 |
| Receivables | 11,090 | 7,813 | 5,397 | 7,329 | 17,371 |
| Inventories | 2,712 | 1,974 | 2,236 | 2,304 | 2,522 |
| Other current assets | 5,020 | 1,374 | 1,958 | 1,959 | 0 |
| TOTAL | $32,639 | $34,129 | $42,539 | $36,275 | $36,781 |
| Non-Current Assets | |||||
| PPE Net | 177 | 191 | 209 | 225 | 315 |
| Other Non-Current Assets | 3,201 | 4,466 | 4,383 | 4,396 | 2,011 |
| TOTAL | $3,378 | $4,657 | $4,592 | $4,621 | $2,326 |
| Total Assets | $36,017 | $38,786 | $47,131 | $40,896 | $39,107 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 12,458 | 12,673 |
| Accounts payable and accrued liabilities | 1,603 | 2,193 | 2,072 | 1,585 | 2,321 |
| Accrued Expenses | 14,548 | 12,251 | 12,837 | 12,600 | 13,101 |
| Other current liabilities | 4,000 | N/A | N/A | N/A | N/A |
| TOTAL | $22,442 | $16,219 | $16,437 | $28,908 | $29,222 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 21,619 | 24,578 |
| Deferred Revenues | 1,335 | 1,031 | 782 | 1,564 | 481 |
| Other Non-Current Liabilities | 8,475 | 5,966 | 5,308 | 6,780 | 2,212 |
| TOTAL | $9,268 | $6,512 | $5,951 | $29,028 | $27,369 |
| Total Liabilities | $31,710 | $22,731 | $22,388 | $57,936 | $56,591 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,179 | 17,179 | 17,179 | 9,490 | 9,446 |
| Common Shares | 2 | 2 | 2 | 1 | 1 |
| Retained earnings | -347,748 | -334,595 | -324,913 | -316,839 | -316,565 |
| TOTAL | $4,307 | $16,055 | $24,743 | $-17,040 | $-17,484 |
| Total Liabilities And Equity | $36,017 | $38,786 | $47,131 | $40,896 | $39,107 |